Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.9b01618
Abstract: The transcriptional repressor B-cell lymphoma 6 (BCL6) is frequently misregulated in diffuse large B-cell lymphoma (DLBCL) and has emerged as an attractive drug target for the treatments of lymphoma. In this article, a series of…
read more here.
Keywords:
potent activities;
phenyl pyrimidinamine;
pyrimidinamine derivatives;
cell ... See more keywords